Diagnosing autoimmune encephalitis involves a combination of clinical evaluation, antibody testing in blood and spinal fluid, brain imaging, electrical brain activity recording, and ruling out infections. There is no single test that confirms or excludes the condition. Instead, doctors work through a layered process, moving from “possible” to “probable” to “definite” diagnosis as evidence accumulates. Because antibody test results can take days or weeks to return, much of the early diagnostic work focuses on recognizing clinical patterns and starting treatment before confirmation arrives.
Clinical Criteria and Symptom Patterns
The diagnostic framework used by most neurologists classifies autoimmune encephalitis into three levels of certainty: possible, probable, and definite. A “possible” diagnosis is based entirely on the clinical picture, which allows treatment to begin quickly while lab results are still pending.
The hallmark presentation is a rapid onset of symptoms over days to a few weeks. Memory problems, seizures, involuntary movements, confusion, and psychiatric symptoms are the most common features. What makes the clinical picture tricky is that many patients first present with psychiatric symptoms alone: anxiety, agitation, hallucinations, personality changes, or mood episodes that look like mania or depression. These psychiatric symptoms tend to be atypical in character, poorly organized, and unusually resistant to standard psychiatric medications. When confusion, seizures, or short-term memory loss develop alongside psychiatric symptoms, autoimmune encephalitis should be strongly considered.
Compared with infectious encephalitis caused by viruses, autoimmune encephalitis is more likely to feature memory deficits, involuntary movements, and seizures as early symptoms. Viral encephalitis, by contrast, more commonly starts with headache and fever. These patterns help doctors begin sorting between the two, though significant overlap exists.
Antibody Testing in Blood and Spinal Fluid
The most definitive piece of evidence is finding a specific antibody that attacks brain tissue. These antibodies target proteins on the surface of neurons or, in some cases, proteins inside cells. The two most commonly identified are NMDA receptor antibodies and LGI1 antibodies, but panels typically test for a broader range.
A critical detail that affects diagnostic accuracy: the best sample to test depends on which antibody you’re looking for. For NMDA receptor antibodies, spinal fluid is far more reliable than blood, with 100% sensitivity in spinal fluid compared to about 85% in blood alone. For LGI1 antibodies, the pattern reverses. Blood is more sensitive (100%) than spinal fluid (around 88%). Because of this, both blood and spinal fluid should be tested. Relying on only one sample risks missing the diagnosis entirely.
Perhaps the most important thing to know about antibody testing is that a negative result does not rule out autoimmune encephalitis. Studies consistently find that 42% to 51% of patients who meet clinical criteria for autoimmune encephalitis never test positive for any known antibody. These “antibody-negative” cases likely involve antibodies that haven’t been identified yet by current testing panels. If the clinical picture is convincing, doctors may still treat with immune therapy even without a positive antibody result.
What Spinal Fluid Reveals
A lumbar puncture (spinal tap) provides spinal fluid for both antibody testing and a general analysis of inflammation. Three basic findings help support the diagnosis before specific antibody results come back.
- Elevated white blood cell count: Normal spinal fluid contains 4 cells per microliter or fewer. An elevated count suggests inflammation in the brain, which points toward encephalitis rather than a purely psychiatric condition.
- Elevated protein: Protein levels above roughly 450 mg/L suggest a disrupted barrier between blood and brain, another sign of an inflammatory process.
- Oligoclonal bands: These are markers of immune activity happening specifically within the nervous system. Finding them in spinal fluid but not in blood supports an autoimmune process in the brain.
The specific pattern of spinal fluid abnormalities varies by subtype. In NMDA receptor encephalitis, elevated white cells and oligoclonal bands both support the diagnosis. In GAD antibody encephalitis, oligoclonal bands are often the only abnormality, with cell counts and protein remaining normal. In IgLON5 disease, elevated protein is the characteristic finding. These patterns can offer early clues about which subtype a patient has, even before antibody results return.
Brain MRI Findings
MRI is part of every autoimmune encephalitis workup, but its role is more nuanced than you might expect. In some subtypes, the MRI is completely normal even when the disease is active. In others, it shows distinctive patterns.
In NMDA receptor encephalitis, the most common MRI finding in the acute stage is… nothing. Most patients have a normal scan. When abnormalities do appear, they tend to be subtle, nonspecific white matter changes that don’t match the severity of symptoms. This is one reason NMDA receptor encephalitis is so often missed early on: a normal MRI can falsely reassure doctors that nothing is wrong.
Several other subtypes show a more recognizable pattern called limbic encephalitis, with bright signal changes on MRI in the medial temporal lobes (the inner part of the brain’s temporal region, which houses memory structures). This pattern is typical of LGI1, CASPR2, and GAD antibody encephalitis. Over time, these areas can shrink, a finding called hippocampal atrophy. GABA-B receptor encephalitis also shows temporal lobe changes but may additionally involve the cerebellum. GABA-A receptor encephalitis looks different again, with widespread, patchy changes across multiple brain regions.
Because MRI findings are so variable, a normal scan never rules out autoimmune encephalitis. The scan’s primary value is often in excluding other causes, such as tumors, strokes, or metastatic cancer compressing the brain.
EEG and Brain Wave Patterns
Electroencephalography (EEG) records electrical activity across the brain’s surface and is abnormal in most patients with autoimmune encephalitis. The most common finding is nonspecific slowing, meaning the brain’s electrical rhythms are running slower than normal, reflecting widespread dysfunction.
One EEG pattern carries special diagnostic weight. Called “extreme delta brush,” it consists of very slow brain waves (1 to 3 cycles per second) with bursts of faster activity (20 to 30 cycles per second) layered on top, most prominent over the front of the brain. This pattern is highly specific to NMDA receptor encephalitis, appearing in about 30% of patients with the condition. While it can rarely occur in other situations like severe brain injury or tumors, finding it in the right clinical context strongly points toward NMDA receptor encephalitis and can guide diagnosis before antibody results are available.
Patients who show extreme delta brush on EEG tend to have a more severe course, with longer hospital stays and slower recovery. So beyond diagnosis, this finding also carries prognostic information.
Screening for Underlying Cancer
Some forms of autoimmune encephalitis are triggered by a tumor elsewhere in the body. The immune system mounts a response against the tumor, but the antibodies it produces also attack brain tissue. This is called a paraneoplastic process, and finding the tumor is a critical part of both diagnosis and treatment.
The association between tumor type and antibody is often predictable. NMDA receptor encephalitis in young women is frequently linked to ovarian teratomas (a type of benign ovarian tumor). Other antibody types are associated with lung cancer, thymus tumors, or breast cancer. Because of these associations, a cancer screening is standard once autoimmune encephalitis is suspected.
CT scans of the chest, abdomen, and pelvis are commonly used, along with pelvic or testicular ultrasound depending on the patient’s sex. Whole-body PET scans, which detect areas of unusually high metabolic activity, can identify tumors that are too small to see on standard imaging. Brain PET scans can also reveal areas of abnormally increased brain activity even when MRI looks normal, potentially catching early-stage inflammation. If no tumor is found initially, repeat screening is often recommended over the following one to two years, since tumors can be very small at the time neurological symptoms first appear.
Distinguishing It From Other Conditions
The diagnostic process also involves systematically ruling out conditions that mimic autoimmune encephalitis. Viral encephalitis is the closest mimic. Herpes simplex virus encephalitis, in particular, can cause similar memory problems, seizures, and temporal lobe changes on MRI. Standard infectious testing of spinal fluid (viral PCR panels, bacterial cultures) is part of every workup. In infectious encephalitis, blood counts tend to be lower across the board (white cells, red cells, and platelets), and spinal fluid protein levels tend to be higher than in autoimmune cases.
Primary psychiatric disorders are another major source of diagnostic confusion, especially early in the course when psychiatric symptoms may be the only feature. Red flags that should prompt investigation for autoimmune encephalitis include rapid onset of psychiatric symptoms in someone without prior psychiatric history, poor response to psychiatric medications, the development of neurological features like seizures or involuntary movements alongside psychiatric symptoms, and confusion or memory problems out of proportion to what the psychiatric diagnosis would explain.
Other conditions in the differential include drug or toxin exposure, metabolic problems like thyroid disease or liver failure, and other inflammatory brain diseases like lupus affecting the nervous system. A thorough workup typically involves blood tests for metabolic and toxic causes alongside the encephalitis-specific testing described above.